SPX 6,124.35 ▲ 0.47%DJI 44,210.18 ▼ 0.12%CCMP 19,875.02 ▲ 0.72%SX5E 5,231.77 ▲ 0.24%UKX 8,402.11 ▼ 0.22%NKY 39,870.50 ▲ 0.78%EURUSD 1.0842 ▼ 0.19%USGG10YR 4.31 ▲ 0.94%CL1 71.82 ▼ 0.88%XAU 2,685.40 ▲ 0.42%XBT 97,250.00 ▲ 1.93%SPX 6,124.35 ▲ 0.47%DJI 44,210.18 ▼ 0.12%CCMP 19,875.02 ▲ 0.72%SX5E 5,231.77 ▲ 0.24%UKX 8,402.11 ▼ 0.22%NKY 39,870.50 ▲ 0.78%EURUSD 1.0842 ▼ 0.19%USGG10YR 4.31 ▲ 0.94%CL1 71.82 ▼ 0.88%XAU 2,685.40 ▲ 0.42%XBT 97,250.00 ▲ 1.93%
 

← Persons Index

Viktor Kharitonin
Rank #486 · Healthcare

Viktor Kharitonin

Pharmaceuticals · Russia

Net worth$7.8B
Today−$29
7 days−$558
30 days−$2.6M

Net worth, last 30 days

Low $7.8BHigh $7.8B

Biography

Viktor Kharitonin created multinational pharmaceutical firm Pharmstandard with Russian billionaire Roman Abramovich and other partners in 2003 by combining five factories.

Kharitonin and partner Egor Kulkov bought out the other investors in 2008, a year after Pharmstandard went public in London. They took Pharmstandard private again, eight years later.

Kharitonin and Kulkov also hold stakes in other Russian pharmaceuticals companies: OTCPharm, Biocad and Generium, one of the producers of the COVID-19 vaccine Sputnik V.

In 2022 The two partners tried to buy Russian assets of Austrian-British packaging and paper group Mondi for 1.5 billion euro, but Russian authorities rejected the deal.

In 2023 Kharitonin and his partners bought Russian assets of German chemical producer Henkel for 600 million euros, leaving Henkel the option of buying back the business.

Did you know

In October 2014 Kharitonin became co-owner of Nurbugring in Germany, one of the oldest race tracks in Europe.

The Novosibirsk State University graduate got his start selling consumer goods.